|
Dec 8
|
Why Is Catalyst (CPRX) Up 16.2% Since Last Earnings Report?
|
|
Dec 7
|
Why Is Esperion Therapeutics (ESPR) Up 51.4% Since Last Earnings Report?
|
|
Nov 14
|
Esperion Therapeutics, Inc.'s (NASDAQ:ESPR) Profit Outlook
|
|
Nov 8
|
Esperion (ESPR) Q3 Earnings Beat, Stock Up on Strong Revenues
|
|
Nov 8
|
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
Esperion Therapeutics Inc (ESPR) Reports 79% Y/Y Growth in Q3 Total Revenue
|
|
Nov 7
|
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates
|
|
Nov 7
|
Esperion Reports Third Quarter 2023 Financial Results
|
|
Jul 7
|
Esperion to Present Additional Data from the CLEAR Outcomes Study on CVD Prevention at the American Society for Preventive Cardiology (ASPC) Congress 2023
|